Reaction Details |
| Report a problem with these data |
Target | Alpha-2B adrenergic receptor |
---|
Ligand | BDBM50263725 |
---|
Substrate/Competitor | n/a |
---|
Meas. Tech. | ChEMBL_535910 (CHEMBL984462) |
---|
Ki | 5.2±n/a nM |
---|
Citation | Patel, SD; Habeski, WM; Min, H; Zhang, J; Roof, R; Snyder, B; Bora, G; Campbell, B; Li, C; Hidayetoglu, D; Johnson, DS; Chaudhry, A; Charlton, ME; Kablaoui, NM Identification and SAR around N-{2-[4-(2,3-dihydro-benzo[1,4]dioxin-2-ylmethyl)-[1,4]diazepan-1-yl]-ethyl}-2-phenoxy-nicotinamide, a selective alpha2C adrenergic receptor antagonist. Bioorg Med Chem Lett18:5689-93 (2008) [PubMed] Article |
---|
More Info.: | Get all data from this article, Assay Method |
---|
|
Alpha-2B adrenergic receptor |
---|
Name: | Alpha-2B adrenergic receptor |
Synonyms: | ADA2B_HUMAN | ADRA2B | ADRA2L1 | ADRA2RL1 | Adrenergic alpha2B | Adrenergic receptor | Adrenergic receptor alpha | Adrenergic, alpha-2B-, receptor [Homo sapiens] | Alpha-2 adrenergic receptor subtype C2 | Alpha-2B adrenoceptor | Alpha-2B adrenoreceptor | Alpha-2BAR |
Type: | Enzyme |
Mol. Mass.: | 49964.20 |
Organism: | Homo sapiens (Human) |
Description: | P18089 |
Residue: | 450 |
Sequence: | MDHQDPYSVQATAAIAAAITFLILFTIFGNALVILAVLTSRSLRAPQNLFLVSLAAADIL
VATLIIPFSLANELLGYWYFRRTWCEVYLALDVLFCTSSIVHLCAISLDRYWAVSRALEY
NSKRTPRRIKCIILTVWLIAAVISLPPLIYKGDQGPQPRGRPQCKLNQEAWYILASSIGS
FFAPCLIMILVYLRIYLIAKRSNRRGPRAKGGPGQGESKQPRPDHGGALASAKLPALASV
ASAREVNGHSKSTGEKEEGETPEDTGTRALPPSWAALPNSGQGQKEGVCGASPEDEAEEE
EEEEEEEEECEPQAVPVSPASACSPPLQQPQGSRVLATLRGQVLLGRGVGAIGGQWWRRR
AQLTREKRFTFVLAVVIGVFVLCWFPFFFSYSLGAICPKHCKVPHGLFQFFFWIGYCNSS
LNPVIYTIFNQDFRRAFRRILCRPWTQTAW
|
|
|
BDBM50263725 |
---|
n/a |
---|
Name | BDBM50263725 |
Synonyms: | 1-((2,3-dihydrobenzo[b][1,4]dioxin-2-yl)methyl)-4-((3-(2-phenoxypyridin-3-yl)-1,2,4-oxadiazol-5-yl)methyl)-1,4-diazepane | CHEMBL491420 |
Type | Small organic molecule |
Emp. Form. | C28H29N5O4 |
Mol. Mass. | 499.561 |
SMILES | C(C1COc2ccccc2O1)N1CCCN(Cc2nc(no2)-c2cccnc2Oc2ccccc2)CC1 |
Structure |
|